The potential role of EHR data in optimizing eligibility criteria definition for cardiovascular outcome trials
Authors:
Open Access
- 25 September 2021
- journal article
- research article
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 156, 104587
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Sodium–glucose co‐transporter‐2 inhibitor cardiovascular outcome trials and generalizability to English primary careDiabetic Medicine, 2020
- Generalizability of Cardiovascular Safety Trials on SGLT2 Inhibitors to the Real World: Implications for Clinical PracticeAdvances in Therapy, 2019
- A Real-Time Automated Patient Screening System for Clinical Trials Eligibility in an Emergency Department: Design and EvaluationJMIR Medical Informatics, 2019
- Eligibility of patients with type 2 diabetes for sodium‐glucose co‐transporter‐2 inhibitor cardiovascular outcomes trials: An assessment using the Diabetes Collaborative RegistryDiabetes, Obesity and Metabolism, 2019
- Report from the 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study GroupCardiovascular Diabetology, 2019
- Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesNew England Journal of Medicine, 2019
- Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From aDiabetes CareEditors’ Expert ForumDiabetes Care, 2017
- Canagliflozin and Cardiovascular and Renal Events in Type 2 DiabetesNew England Journal of Medicine, 2017
- Feasibility and utility of applications of the common data model to multiple, disparate observational health databasesJournal of the American Medical Informatics Association, 2015
- Mortality and causes of death in the WHO multinational study of vascular disease in diabetesDiabetologia, 2001